Moleculin Biotech, Inc.

MBRXNASDAQUSD
2.32 USD
0.00 (0.00%)AT CLOSE (11:59 AM EDT)
2.33
0.03 (1.08%)
POST MARKET (AS OF 04:28 PM EDT)
Post Market
AS OF 04:28 PM EDT
2.33
0.03 (1.08%)
🟢Market: OPEN
Open?$2.30
High?$2.35
Low?$2.26
Prev. Close?$2.32
Volume?41.2K
Avg. Volume?146.8K
VWAP?$2.31
Rel. Volume?0.28x
Bid / Ask
Bid?$1.96 × 100
Ask?$2.73 × 100
Spread?$0.77
Midpoint?$2.34
Valuation & Ratios
Market Cap?12.4M
Shares Out?5.3M
Float?3.0M
Float %?98.0%
P/E Ratio?N/A
P/B Ratio?0.83
EPS?-$4.50
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?1.41Adequate
Quick Ratio?1.41Adequate
Cash Ratio?1.30Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUED
Score
100/100
P/E?
N/A
P/B?
0.83CHEAP
P/S?
N/A
P/FCF?
N/A
EV/EBITDA?
-0.1CHEAP
EV/Sales?
N/A
Returns & Efficiency
ROE?
-160.1%WEAK
ROA?
-108.6%WEAK
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$3.5M
Related Companies
Loading...
News
Profile
Moleculin Biotech Inc is a late-stage pharmaceutical development company currently evaluating Annamycin, also known as L-Annamycin and by its generic name naxtarubicin. The company has two additional portfolios of technologies for hard-to-treat cancers and viruses with clinical and preclinical research funded by investigators at academic institutions. The Company operates in one reportable segment, which is the development and commercialization of drug products.
Employees
17
Market Cap
12.4M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2016-06-02
Address
5300 MEMORIAL DRIVE
HOUSTON, TX 77007
Phone: 713-300-5160